<?xml version="1.0" encoding="UTF-8"?>
<ref id="B94">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Weiland</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Ahlen</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Diepolder</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Jung</surname>
    <given-names>M. C.</given-names>
   </name>
   <name>
    <surname>Levander</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Fons</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2013</year>). 
  <article-title>Therapeutic DNA vaccination using 
   <italic>in vivo</italic> electroporation followed by standard of care therapy in patients with genotype 1 chronic hepatitis C
  </article-title>. 
  <source>Mol. Ther.</source>
  <volume>21</volume>, 
  <fpage>1796</fpage>â€“
  <lpage>1805</lpage>. 
  <pub-id pub-id-type="doi">10.1038/mt.2013.119</pub-id>
  <?supplied-pmid 23752314?>
  <pub-id pub-id-type="pmid">23752314</pub-id>
 </mixed-citation>
</ref>
